British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...
GSK's specialty medicines segment showed strong performance, growing over 20% due to successful new launches. Additionally, GSK is currently undervalued, trading at £16.1, significantly below the ...
The company's strategic focus on innovation, particularly in R&D, is evident from its investments in new vaccines and medicines, combining scientific focus on the immune system with advanced ...
GSK's new long-acting drug candidate for severe asthma, depemokimab, reduced the rate of severe attacks by 54% in a pair of phase 3 trials presented at the European Respiratory Society (ERS ...
(RTTNews) - Drug maker GSK plc (GSK, GSK.L ... Labour and Welfare or MHLW has accepted for review a new drug application (NDA) for Blenrep in combination with bortezomib plus dexamethasone ...
Miels said the new plan includes “changing our marketing mix to focus on segments who are tougher to activate.” Making Shields part of the marketing mix has enabled GSK to win mainstream media ...
(RTTNews) - Drug maker GSK plc (GSK, GSK.L) confirmed Wednesday that it has reached two confidential settlements in cases filed in California State Court against heartburn drug Zantac (ranitidine ...
GSK touts co-administration data for RSV, shingles vaccines as narrowed CDC guidance threatens sales
This summer, GSK cut its yearly vaccine sales projection ... With sales of its flagship shingles vaccine Shingrix separately faltering, new data on co-administration of the two adult vaccines ...
The new vaccine is a combination of GSK’s already-approved vaccines Bexsero and Menveo and is designed to protect against meningitis and blood poisoning caused by the A, B, C, W, and Y ...
Voyager, a computer program, played with Ensemble Signal in the U.S. premiere of a ... Macdonald’s memoir “H Is for Hawk.” By The New York Times The museum has announced the fall season ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback